Yes, I added to my position a few weeks ago. The pullback after the bad news in Sept has provided a nice buying opportunity,in my opinion.

I view my ROSG investment as a long term investment. I would like to see them succeed on their own without having to sell out to big pharma or another biotech. I think it would be difficult at this point to determine an acquisition price for Rosetta that accurately and fairly values its' assets and commercial products.

The three commercial microRNA tests are new to the world. How can anyone accurately estimate future earnings streams from them?

Researchers have just started to uncover new insights into how microRNAs regulate cellular processes. Rosetta has discovered hundreds of novel microRNAs over the years. How can anyone accurately estimate the true commercial value of these microRNAs today or what that value will be 5 years from now?